4D Molecular Therapeutics Inc - fluxo de caixa trimestral (NASDAQ:FDMT) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total assets 560.38 M515.73 M473.64 M423.98 M566.71 M Total liabilities 49.78 M46.01 M52.75 M55 M61.05 M Total equity 510.61 M469.72 M420.89 M368.98 M505.66 M Total liabilities & shareholders' equities 560.38 M515.73 M473.64 M423.98 M566.71 M Total debt ————— Net debt —————

Notícias

electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?

Jefferies reduz preço-alvo da 4D Molecular Therapeutics por avaliação

RBC Capital eleva preço-alvo das ações da 4D Molecular após avanços no pipeline

Lucro da 4D Molecular superou projeções por $0,96; receita supera estimativas

4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates

4D Molecular Therapeutics, Inc. (FDMT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:FDMT) 2026-01-19

RBC Capital reitera classificação Outperform para ações da 4D Molecular com preço-alvo de US$ 32

RBC Capital reiterates Outperform rating on 4D Molecular stock at $32

Ashoo Gupta da 4D Molecular Therapeutics vende US$ 3.376 em ações FDMT

Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock

4D Molecular Therapeutics: Jury Still Out On CF Gene Therapy After Dense Data Drop (NASDAQ:FDMT)